MedTrace Logo

Imagery Vividness and Arousal Responses to Prospective Imagery

NCT04370613 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-10-19

No results posted yet for this study

Summary

Research has shown that mental imagery appears to carry emotion better than verbal communication. One way this can be noted is that emotional mental imagery trigger physiological arousal responses. These may be important for treatment techniques using mental imagery, such as imaginal exposure and imagery re-scripting. However, as the development of clinical applications increasingly considers the use of flashpoint imagery, i.e. mental imagery of short duration, it is of interest to examine whether also flashpoint imagery trigger arousal responses. This study examines the arousal response to flashpoint imagery of different valence (positive, negative, and neutral).

Moreover, emerging evidence suggest that depressed individuals find it more difficult to produce mental imagery of positive future events (less accessible and vivid) than healthy controls. In addition, individuals with clinical anxiety appear to be able to produce imagery of negative future events more easily than healthy controls. This study explores whether these results can be noted also in sub-clinical symptoms of depression and anxiety, and if so, if they are accompanied with corresponding changes in arousal responses.

Conditions

  • Healthy

Interventions

BEHAVIORAL

Prospective Imagery visualization task

Participant visualizes brief mental imagery of prospective situations of different valence (neutral, positive, negative).

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

Principal Investigators

  • Thomas Ågren, PhD · Uppsala University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-05
Primary Completion
2021-10-15
Completion
2021-10-15

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04370613 on ClinicalTrials.gov